Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats
Open Access
- 1 April 2004
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 286 (4), R699-R709
- https://doi.org/10.1152/ajpregu.00593.2003
Abstract
Although circulatory shock related to lethal toxin (LeTx) may play a primary role in lethality due to Bacillus anthracis infection, its mechanisms are unclear. We investigated whether LeTx-induced shock is associated with inflammatory cytokine and nitric oxide (NO) release. Sprague-Dawley rats with central venous and arterial catheters received 24-h infusions of LeTx (lethal factor 100 μg/kg; protective antigen 200 μg/kg) that produced death beginning at 9 h and a 7-day mortality rate of 53%. By 9 h, mean arterial blood pressure, heart rate, pH, and base excess were decreased and lactate and hemoglobin levels were increased in LeTx nonsurvivors compared with LeTx survivors and controls (diluent only) ( P ≤ 0.05 for each comparing the 3 groups). Despite these changes, arterial oxygen and circulating leukocytes and platelets were not decreased and TNF-α, IL-1β, IL-6, and IL-10 levels were not increased comparing either LeTx nonsurvivors or survivors to controls. Nitrate/nitrite levels and tissue histology also did not differ comparing LeTx animals and controls. In additional experiments, although 24-h infusions of LeTx and Esherichia coli LPS produced similar mortality rates (54 and 56%, respectively) and times to death (13.2 ± 0.8 vs. 11.0 ± 1.7 h, respectively) compared with controls, only LPS reduced circulating leukocytes, platelets, and IL-2 levels and increased TNF-α, IL-1α and -1β, IL-6, IL-10, interferon-γ, granulocyte macrophage-colony stimulating factor, RANTES, migratory inhibitory protein-1α, -2, and -3, and monocyte chemotactic protein-1, as well as nitrate/nitrite levels (all P ≤ 0.05 for the effects of LPS). Thus, in contrast to LPS, excessive inflammatory cytokine and NO release does not appear to contribute to the circulatory shock and lethality occurring with LeTx in this rat model. Although therapies to modulate these host mediators may be applicable for shock caused by LPS or other bacterial toxins, they may not with LeTx.Keywords
This publication has 33 references indexed in Scilit:
- Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracisJournal of Industrial Microbiology & Biotechnology, 2002
- AnthraxAnnual Review of Microbiology, 2001
- Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ‐induced release of NO and TNFαFEBS Letters, 1999
- Anthrax lethal factor cleaves the N-terminus of MAPKKS and induces tyrosine/threonine phosphorylation of MAPKS in cultured macrophagesJournal of Applied Microbiology, 1999
- Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.The Journal of Experimental Medicine, 1989
- Pathogenesis of hypotension in septic shockCritical Care Medicine, 1988
- Anthrax Toxin: Primary Site of ActionThe Journal of Infectious Diseases, 1968
- In vivo effects of Bacillus anthracis culture filtrates*The Journal of Infectious Diseases, 1963
- Anthrax Toxin: Causative Agent in the Death of Rhesus MonkeysScience, 1962
- Observations on Experimental Anthrax: Demonstration of a Specific Lethal Factor produced in vivo by Bacillus anthracisNature, 1954